We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+8.27%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$21.8B
AUM Growth
+$3.36B
(+18%)
Cap. Flow
+$2.78B
Cap. Flow
% of AUM
12.74%
Top 10 Holdings %
Top 10 Hldgs %
12.04%
Holding
3,109
New
1,280
Increased
559
Reduced
519
Closed
699
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARA
Paramount Global Class B
PARA
|
+$363M |
| 2 |
Tencent Music
TME
|
+$184M |
| 3 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$182M |
| 4 |
Baidu
BIDU
|
+$146M |
| 5 |
Gaotu Techedu
GOTU
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$204M |
| 2 |
Carnival Corporation Ltd
CCL
|
+$189M |
| 3 |
Zoetis
ZTS
|
+$182M |
| 4 |
Guardant Health
GH
|
+$136M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.03% |
| 2 | Consumer Discretionary | 13.15% |
| 3 | Technology | 10.68% |
| 4 | Financials | 9.81% |
| 5 | Communication Services | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PLXP
1226
DELISTED
PLx Pharma Inc. Common Stock
PLXP
| $2.4M | 0.01% |
+265,462
| New | +$1.94M |
|
1227
Neogen
NEOG
$2.04B
| $2.39M | 0.01% |
53,792
-142,472
| -73% | -$5.97M |
|
1228
Afya
AFYA
$1.32B
| $2.38M | 0.01% |
128,155
+87,643
| +216% | +$1.98M |
|
1229
DuPont de Nemours
DD
$19.1B
| $2.38M | 0.01% |
24,515
+5,679
| +30% | +$544K |
|
1230
SK Telecom
SKM
$11.9B
| $2.37M | 0.01% |
+52,918
| New | +$2.19M |
|
1231
Perdoceo Education
PRDO
$2.06B
| $2.37M | 0.01% |
197,740
-282,910
| -59% | -$3.58M |
|
|
CAHCW
1232
CALL
DELISTED
CA Healthcare Acquisition Corp. Warrant
CAHCW
| $2.36M | 0.01% |
+242,426
| New | +$184K |
|
1233
Martin Marietta Materials
MLM
$35B
| $2.36M | 0.01% |
+7,031
| New | +$2.25M |
|
|
BGRY
1234
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
| $2.36M | 0.01% |
+232,476
| New | +$2.51M |
|
1235
Brunswick
BC
$5.37B
| $2.35M | 0.01% |
+24,661
| New | +$2.26M |
|
|
NOA
1236
North American Construction
NOA
$368M
| $2.35M | 0.01% |
218,549
+61,386
| +39% | +$660K |
|
|
CYXTW
1237
CALL
DELISTED
Cyxtera Technologies, Inc. Warrant
CYXTW
| $2.35M | 0.01% |
236,661
+70,000
| +42% | +$153K |
|
|
1238
PUT
Baidu
BIDU
$35.7B
| $2.35M | 0.01% |
+10,800
| New | +$2.82M |
|
|
FCAX
1239
DELISTED
Fortress Capital Acquisition Corp.
FCAX
| $2.35M | 0.01% |
+239,289
| New | +$2.36M |
|
1240
Ferguson
FERG
$44.9B
| $2.35M | 0.01% |
+19,606
| New | +$2.39M |
|
|
RACB
1241
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
| $2.34M | 0.01% |
+228,700
| New | +$2.34M |
|
1242
Jones Lang LaSalle
JLL
$15.9B
| $2.33M | 0.01% |
13,008
-8,833
| -40% | -$1.44M |
|
|
TRUE
1243
DELISTED
TrueCar
TRUE
| $2.33M | 0.01% |
485,833
+365,647
| +304% | +$1.81M |
|
1244
J.M. Smucker
SJM
$13.2B
| $2.31M | 0.01% |
18,285
+14,072
| +334% | +$1.66M |
|
|
BFIIW
1245
CALL
DELISTED
BurgerFi International, Inc. Warrant
BFIIW
| $2.31M | 0.01% |
+150,000
| New | +$435K |
|
1246
HEICO Corp
HEI
$50.6B
| $2.31M | 0.01% |
18,366
+6,384
| +53% | +$820K |
|
1247
AngloGold Ashanti
AU
$40.3B
| $2.31M | 0.01% |
105,100
+68,703
| +189% | +$1.54M |
|
|
NVSAU
1248
DELISTED
New Vista Acquisition Corp Unit
NVSAU
| $2.3M | 0.01% |
+230,401
| New | +$2.38M |
|
|
MODN
1249
DELISTED
MODEL N, INC.
MODN
| $2.3M | 0.01% |
+65,303
| New | +$2.51M |
|
1250
Krystal Biotech
KRYS
$10.5B
| $2.3M | 0.01% |
29,836
+22,409
| +302% | +$1.63M |
|
Similar funds
Marshall Wace's Q1 2021 Portfolio in Review
As of Q1 2021, Marshall Wace held 3,109 positions worth $21.8B, up 18% from $18.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Marshall Wace deployed $2.78B of net new capital in Q1 2021, opening 1,280 new positions and adding to 559 existing holdings. Its largest new stake was Paramount Global Class B: 5,936,494 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $204M trimmed.
- Marshall Wace's largest Q1 2021 buy was Paramount Global Class B: 5,936,494 shares worth $268M.
- Marshall Wace added most to Farfetch Limited Class A Ordinary Shares in Q1 2021, an estimated $182M increase.
- Marshall Wace's biggest Q1 2021 reduction was Thermo Fisher Scientific, cutting an estimated $204M.
- Marshall Wace fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q1 2021, selling an estimated $76.2M.
- Marshall Wace's ten largest holdings make up 12% of its $21.8B portfolio in Q1 2021.
- Marshall Wace opened 1,280 new positions and closed 699 in Q1 2021.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $21.8B.
Based on Marshall Wace's 13F filing for Q1 2021, filed 17 May 2021.